Identification of candidate target genes of pituitary adenomas based on the DNA microarray

Zhou,Wei; Ma,Chun-Xiao; Xing,Ya-Zhou; Yan,Zhao-Yue

doi:10.3892/mmr.2016.4785

Identification of candidate target genes of pituitary adenomas based on the DNA microarray

Authors:
- Wei Zhou
- Chun-Xiao Ma
- Ya-Zhou Xing
- Zhao-Yue Yan
View Affiliations

Affiliations: Department of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China
Published online on: January 14, 2016 https://doi.org/10.3892/mmr.2016.4785
Pages: 2182-2186

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore molecular mechanisms involved in pituitary adenomas (PAs) and to discover target genes for their treatment. The gene expression profile GSE4488 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified using the Limma package and analyzed by two‑dimensional hierarchical clustering. Gene ontology (GO) and pathway enrichment analyses were performed in order to investigate the functions of DEGs. Subsequently, the protein‑protein interaction (PPI) network was constructed using Cytoscape software. DEGs were then mapped to the connectivity map database to identify molecular agents associated with the underlying mechanisms of PAs. A total of 340 upregulated and 49 downregulated DEGs in PA samples compared with those in normal controls were identified. Hierarchical clustering analysis showed that DEGs were highly differentially expressed, indicating their aptness for distinguishing PA samples from normal controls. Significant gene ontology terms were positive regulation of immune system-associated processes for downregulated DEGs and skeletal system development for upregulated DEGs. Pathways significantly enriched by DEGs included extracellular matrix (ECM)‑receptor interaction, the Hedgehog (Hh) signaling pathway and neuroactive ligand‑receptor interaction. The PPI network was constructed with 117 nodes, 123 edges and CD44 and Gli2 as hub nodes. Furthermore, depudecin, a small molecule drug, was identified to be mechanistically associated with PA. The genes CD44 and Gli2 have important roles in the progression of PAs via ECM‑receptor interaction and the Hh signaling pathway and are therefore potential target genes of PA. In addition, depudecin may be a candidate drug for the treatment of PAs.

View Figures

View References

1	Karavitaki N: Prevalence and incidence of pituitary adenomas. Ann Endocrinol (Paris). 73:79–80. 2012. View Article : Google Scholar
2	Aflorei ED and Korbonits M: Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol. 117:379–394. 2014. View Article : Google Scholar : PubMed/NCBI
3	Kokshoorn NE, Romijn JA, Roelfsema F, Rambach AH, Smit JW, Biermasz NR and Pereira AM: The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas. Pituitary. 15:436–444. 2012. View Article : Google Scholar :
4	Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, et al: Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease. N Engl J Med. 362:1846–1848. 2010. View Article : Google Scholar : PubMed/NCBI
5	Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, et al: Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab. 93:2454–2462. 2008. View Article : Google Scholar : PubMed/NCBI
6	Newell-Price J, Bertagna X, Grossman AB and Nieman LK: Cushing's syndrome. Lancet. 367:1605–1617. 2006. View Article : Google Scholar : PubMed/NCBI
7	Tritos NA, Biller BM and Swearingen B: Management of Cushing disease. Nat Rev Endocrinol. 7:279–289. 2011. View Article : Google Scholar : PubMed/NCBI
8	Gong J, Diao B, Yao GJ, Liu Y and Xu GZ: Analysis of regulatory networks constructed based on gene coexpression in pituitary adenoma. J Genet. 92:489–497. 2013. View Article : Google Scholar : PubMed/NCBI
9	Lampichler K, Ferrer P, Vila G, et al: The role of GLI1 in pituitary tumor formation and pituitary cell survival. 2013.
10	Cazabat L, Bouligand J and Chanson P: AIP mutation in pituitary adenomas. N Engl J Med. 364:1973–1974. 2011. View Article : Google Scholar : PubMed/NCBI
11	Riester A, Issler O, Spyroglou A, Rodrig SH, Chen A and Beuschlein F: ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland. Endocrinology. 153:212–222. 2012. View Article : Google Scholar
12	Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, et al: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 312:1228–1230. 2006. View Article : Google Scholar : PubMed/NCBI
13	Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP: Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249–264. 2003. View Article : Google Scholar : PubMed/NCBI
14	Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 3:Article3. 2004.
15	BRIDGES JRCC: Hierarchical cluster analysis. Psychological reports. 18:851–854. 1966. View Article : Google Scholar
16	Team RC: R: A language and environment for statistical computing. 2012.
17	Hulsegge I, Kommadath A and Smits MA: Globaltest and GOEAST: Two different approaches for gene ontology analysis. BMC Proc. 3(Suppl 4): S102009. View Article : Google Scholar : PubMed/NCBI
18	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
19	Altermann E and Klaenhammer TR: PathwayVoyager: Pathway mapping using the kyoto encyclopedia of genes and genomes (KEGG) database. BMC Genomics. 6:602005. View Article : Google Scholar : PubMed/NCBI
20	Zhang B, Kirov S and Snoddy J: WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
21	Duncan D, Prodduturi N and Zhang B: WebGestalt2: An updated and expanded version of the Web-based Gene Set Analysis Toolkit. Bmc Bioinformatics. 11(Suppl 4): P102010. View Article : Google Scholar
22	Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al: The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39:D561–D568. 2011. View Article : Google Scholar :
23	Kohl M, Wiese S and Warscheid B: Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar
24	Lamb J: The Connectivity Map: A new tool for biomedical research. Nat Rev Cancer. 7:54–60. 2007. View Article : Google Scholar
25	Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et al: The Connectivity Map: Using gene-expression signatures to connect small molecules, genes and disease. Science. 313:1929–1935. 2006. View Article : Google Scholar : PubMed/NCBI
26	Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, et al: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 312:1228–1230. 2006. View Article : Google Scholar : PubMed/NCBI
27	Nagano O and Saya H: Mechanism and biological significance of CD44 cleavage. Cancer Sci. 95:930–935. 2004. View Article : Google Scholar : PubMed/NCBI
28	Tsukita S, Oishi K, Sato N, Sagara J, Kawai A and Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 126:391–401. 1994. View Article : Google Scholar : PubMed/NCBI
29	Lesley J and Hyman R: CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol. 22:2719–2723. 1992. View Article : Google Scholar : PubMed/NCBI
30	Weber GF, Ashkar S, Glimcher MJ and Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:509–512. 1996. View Article : Google Scholar : PubMed/NCBI
31	Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 4:33–45. 2003. View Article : Google Scholar : PubMed/NCBI
32	Toole BP: Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer. 4:528–539. 2004. View Article : Google Scholar : PubMed/NCBI
33	Jaracz S, Chen J, Kuznetsova LV and Ojima I: Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 13:5043–5054. 2005. View Article : Google Scholar : PubMed/NCBI
34	Frank S, Rihs H-P, Stöcker W, Müller J, Dumont B, Baur X, Schackert HK and Schackert G: Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Biochem Biophys Res Commun. 222:794–801. 1996. View Article : Google Scholar : PubMed/NCBI
35	Duan Bo ZH and Li Xinjian: Expression and relationship between CD44 and Ki-67 in invasive pituitary adenomas. Cancer Res Prev Treat. 33:490–492. 2006.
36	Rubinfeld H, Cohen-Kaplan V, Nass D, Ilan N, Meisel S, Cohen ZR, Hadani M, Vlodavsky I and Shimon I: Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cells. Endocrinology. 152:4562–4570. 2011. View Article : Google Scholar : PubMed/NCBI
37	Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI
38	Pan Y, Han C, Wang C, Hu G, Luo C, Gan X, Zhang F, Lu Y and Ding X: ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1. J Mol Endocrinol. 49:21–33. 2012. View Article : Google Scholar : PubMed/NCBI
39	Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A and Muenke M: Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA. 100:13424–13429. 2003. View Article : Google Scholar : PubMed/NCBI
40	Devine CA, Sbrogna JL, Guner B, Osgood M, Shen MC and Karlstrom RO: A dynamic Gli code interprets Hh signals to regulate induction, patterning and endocrine cell specification in the zebrafish pituitary. Dev Biol. 326:143–154. 2009. View Article : Google Scholar
41	Vila G, Theodoropoulou M, Stalla J, Tonn JC, Losa M, Renner U, Stalla GK and Paez-Pereda M: Expression and function of sonic hedgehog pathway components in pituitary adenomas: Evidence for a direct role in hormone secretion and cell proliferation. J Clin Endocrinol Metab. 90:6687–6694. 2005. View Article : Google Scholar : PubMed/NCBI
42	Ruiz i Altaba A, Palma V and Dahmane N: Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci. 3:24–33. 2002. View Article : Google Scholar : PubMed/NCBI
43	Matsumoto M, Matsutani S, Sugita K, Yoshida H, Hayashi F, Terui Y, Nakai H, Uotani N, Kawamura Y and Matsumoto K: Depudecin: A novel compound inducing the flat phenotype of NIH3T3 cells doubly transformed by ras-and src-oncogene, produced by Alternaria brassicicola. J Antibiot (Tokyo). 45:879–885. 1992. View Article : Google Scholar
44	Oikawa T, Onozawa C, Inose M and Sasaki M: Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo. Biol Pharm Bull. 18:1305–1307. 1995. View Article : Google Scholar : PubMed/NCBI
45	Shimada J, Kwon HJ, Sawamura M and Schreiber SL: Synthesis and cellular characterization of the detransformation agent, (−)-depudecin. Chem Biol. 2:517–525. 1995. View Article : Google Scholar : PubMed/NCBI
46	Kwon HJ, Owa T, Hassig CA, Shimada J and Schreiber SL: Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci USA. 95:3356–3361. 1998. View Article : Google Scholar : PubMed/NCBI
47	Chen H and Kunnimalaiyaan M: Modulating notch1 signaling pathway for treating neuroendocrine tumors. US Patent 8338482 B2. Filed July 20, 2007; issued December 25, 2012.